packageDaclatasvir

daclatasvir

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Daclatasvir is an antiviral drug used to treat chronic hepatitis C, including in patients with liver cirrhosis. It was authorised in the European Union but that authorisation has expired, so it is no longer marketed there, though it has been included in the WHO essential medicines list.

Summary written by glm-5.3-flash from Wikidata Q5207712 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:daclatasvir
ATC codes:J05AP07
DrugBank:DB09102
PubChem CID:25154714
ChEBI:82977
Wikidata:Q5207712
formula:C40H50N8O6
molar mass:738.89 g/mol (PubChem CID 25154714)
logP:5.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown